Inactive Instrument

News StemCells Inc Nasdaq

Stocks

US85857R2040

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

08-14	B. Riley Adjusts Price Target on Microbot Medical to $4 From $5, Maintains Buy Rating	MT
08-11	Microbot Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

All News

Mentions Relevance

08-14	B. Riley Adjusts Price Target on Microbot Medical to $4 From $5, Maintains Buy Rating	MT
08-11	Microbot Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-11	Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter	GL
08-11	Microbot Medical Inc. Announces Revenue Results for the Second Quarter Ended June 30, 2026	CI
07-21	Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting	GL
07-07	Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026	GL
06-30	Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader	GL
06-25	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System	GL
06-25	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System	AQ
06-23	Microbot Medical Announces First Health System in Pennsylvania to Adopt the Liberty Endovascular Robotic System	CI
06-23	Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System	GL
06-17	Microbot Medical Enters into an Agreement to Expand Access for America's Veteran and Military Patient Populations	AQ
06-16	Microbot Medical Inc. Enters Into Agreement With Lovell Government Services To Expand Access For America?s Veteran And Military Patient Populations	CI
06-16	Microbot Medical Enters Agreement Expanding Access to Federal Healthcare Systems	MT
06-16	Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations	GL
06-09	Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System	GL
06-09	Microbot Medical Inc. Announces A Notable Health System as the First in Michigan to Adopt the Liberty Endovascular Robotic System	CI
06-02	Microbot Medical Inc. Secures First North Carolina Healthcare System to Adopt the LIBERTY Endovascular Robotic System	CI
06-02	Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System	GL
05-26	Microbot Medical Inc. Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY Endovascular Robotic System	CI
05-26	Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System	GL
05-18	Microbot Medical Inc. - Shareholder/Analyst Call
05-15	Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu	GL
05-14	Microbot Medical recorded revenue during its quarter ended March 31, benefiting from limited market release of Liberty System	RE
05-14	Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026	GL